Robert E. Winkler

Robert E. Winkler, MD has accumulated significant work experience in the pharmaceutical and biotech industries. Robert E.'smost recent role is as the Chief Medical Officer at Zentalis Pharmaceuticals since November 2018. Robert E. is also a valued member of the Board of Directors and Advisor at MyChild'sCancer, where their vision is to ensure life-saving information is accessible to parents and caregivers of children with cancer. Additionally, they serve as a Strategic Advisor at TrialJectory, and a member of the Board of Medical Advisors at Neurotez, Inc. Prior to these roles, Dr. Winkler held various senior positions at companies such as TAIHO ONCOLOGY INC, Profounda, Inc, Array BioPharma, Aptalis, Amicus Therapeutics, and Novartis Oncology, focusing on clinical research, development, and operations.

Robert E. Winkler, MD attended Rutgers Business School from 2012 to 2013, where they pursued Executive Education. Prior to that, they obtained their MD degree in Medicine from The Hebrew University of Jerusalem, completing their studies from 1987 to 1994.